Newsletter | January 20, 2026

01.20.26 -- STREAM Edition: Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos

Selecting The Right Vendors When Building Your Supply Chain

Video | Cell & Gene

What factors should you consider when looking for supply chain vendors? This segment of a Cell & Gene digital live event delves into a variety of factors for your ideal supply chain.

The Road To Approval: Viral Clearance Strategies For Non-Enveloped Viral Vectors

Webinar | MilliporeSigma

Know the differences between designing a viral clearance study for non-enveloped viral vectors versus those for mAbs or recombinant proteins, as well as how to identify and remove viral contaminants.

Transforming T-Cell Manufacturing Via Elutriation With Korus

Webinar | Invetech

Learn about a system that uses a gentle elutriation process to give manufacturers a cleaner cell population to begin cell therapy production processes such as CAR-T.

Keys To A Successful cGMP Manufacturing Operation Delivering CGTs

Webinar | Lonza

Uncover the secrets behind successes in commercializing and producing commercial cell and gene therapies, including establishing standards of every day, manufacturing operational excellence.

Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos

Video | Life Science Leader

On this week's episode of the Business of Biotech, Nick Manusos, CEO at Kenai Therapeutics, talks about his experiences building cell therapy spinouts from FujiFilm Cellular Dynamics, learning from big pharma decision-making processes, and dosing the first patient with Kenai's allogeneic neuron replacement cell therapy for Parkinson's disease.